You are here
Strong growth in sales, up 10.9%, at constant exchange rates and scope of consolidation in the first half of 2016: Sales reached €1,001 million Up 7.2% as reported Growth continued to be led by the Americas in the second quarter, supported by the return to faster gains in the Asia-Pacific region All of the clinical and industrial lines contributed to consolidated growth Excellent 62% increase in FilmArray® sales in the second quarter
With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases.
bioMérieux riceve l'approvazione dell'FDA per il più ampio utilizzo di VIDAS® B•R•A•H•M•S PCT™ per la gestione di pazienti con sepsi ad elevato rischio di mortalità
Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients